Natalie Bee, PA
Physician Assistant · Salt Lake City, UTNPI 1841701760
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $56,547 of the $62,519 with a category attached, or 90.4%. 23 manufacturers reported payments, led by Organon at 47.3% of the total. Reporting peaked in 2021 at $34,105 and has fallen 78.1% since, to $7,485 in 2025. Among physician assistant clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 290 payments — averaging $215.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organon$30K
- Biohaven Pharmaceuticals, Inc.$27K
- Biohaven Pharmaceutical Holding Company Ltd.$3K
- AbbVie$1K
- Novo Nordisk$178
- Takeda Pharmaceuticals U.S.A., Inc.$159
- plus $693 from 17 others
What the payments were for
- Consulting fees$8001%
- Speaking & faculty fees$56,54790%
- Travel & lodging$1,3042%
- Food & beverage$3,8566%
- Education$120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organon | 41 | $29,592 |
| Biohaven Pharmaceuticals, Inc. | 76 | $27,163 |
| Biohaven Pharmaceutical Holding Company Ltd. | 22 | $3,269 |
| AbbVie(2 entities) | 88 | $1,464 |
| Novo Nordisk | 17 | $178 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $159 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Gilead | 5 | $89 |
| Amarin Pharma, Inc. | 6 | $85 |
| Lucid Diagnostics Inc. | 3 | $78 |
| Lilly USA, LLC | 4 | $61 |
| Viiv Healthcare Company | 4 | $53 |
| Merck | 2 | $41 |
| AstraZeneca | 2 | $25 |
| Boehringer Ingelheim | 1 | $24 |
| Ultragenyx Pharmaceutical Inc. | 1 | $20 |
| Bayer | 1 | $18 |
| Agile Therapeutics, Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
| Upsher-smith Laboratories LLC | 1 | $12 |
| Impel Pharmaceuticals Inc. | 1 | $12 |
| Amgen | 1 | $11 |
| Dynavax Technologies Corporation | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$29,037
- NEXPLANON$24,035
- VOQUEZNA$125
- VRAYLAR$125
- UBRELVY$109
How this compares
$62,519 in reported general payments places this provider in the 95th percentile of 1,543 physician assistant providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 26 | $30,548 |
| TrulicityDulaglutide | 13 | $16,808 |
| XareltoRivaroxaban | 14 | $14,068 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $1,712 |
| Bupropion XlBupropion Hcl | 35 | $1,333 |
| Gabapentin | 56 | $1,325 |
| Duloxetine Hcl | 35 | $1,237 |
| Omeprazole | 70 | $1,037 |
| ValacyclovirValacyclovir Hcl | 17 | $892 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 35 | $844 |
| Rosuvastatin Calcium | 25 | $808 |
| Atorvastatin Calcium | 111 | $734 |
| Trazodone Hcl | 45 | $700 |
| Levothyroxine Sodium | 81 | $613 |
| Lisinopril | 79 | $397 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $178 | $30,54826 claims |
| Lilly USA, LLCTrulicity | $61 | $16,80813 claims |
| Johnson & JohnsonXarelto | $14 | $14,06814 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,543 physician assistant providers in Utah.
Other physician assistant in Salt Lake City
- Jill EricksonSalt Lake City$179K
- Samuel ShewanSalt Lake City$22K
- Christy MaSalt Lake City$17K
- Shane FarrSalt Lake City$14K
- Gintare DaileySalt Lake City$13K
- Corey DahlSalt Lake City$13K
- David JonesSalt Lake City$12K
- Corbin WoodSalt Lake City$12K
- Amy HillierSalt Lake City$11K
- Angela KirkSalt Lake City$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.